D-dimer as a predictive and prognostic marker among COVID-19 patients.
D-dimer
Najran
platelets count
thrombocytopenia
Journal
Saudi medical journal
ISSN: 1658-3175
Titre abrégé: Saudi Med J
Pays: Saudi Arabia
ID NLM: 7909441
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
13
03
2022
accepted:
13
06
2022
entrez:
13
7
2022
pubmed:
14
7
2022
medline:
16
7
2022
Statut:
ppublish
Résumé
To examine D-dimer, coagulation profile, and platelet count among patients hospitalized with coronavirus disease-19 (COVID-19) and compare them to findings from non-COVID-19 subjects. The participants in this retrospective hospital-based observational study design included 112 confirmed diagnosed with COVID-19 who were admitted to King Khaled Hospital, Najran, Saudi Arabia, and another 112 non-COVID-19 subjects as a comparative group. Laboratory investigations, demographic and clinical records were obtained from participants' electronic indexed medical records. Coronavirus disease-19 diagnosis was confirmed according to positive real time polymerase chain reaction assay carried out at the hospital's central laboratory, where samples were extracted from a nasopharyngeal swab. Pneumonia related to COVID-19 is classified as critical, severe, moderate, mild, and asymptomatic whereas thrombocytopenia was marked when the platelet count was <150.00×10 The D-dimer and activated partial thromboplastin clotting time mean values were significantly elevated ( D-dimer mean values increased significantly in deceased COVID-19 and in hospitalized intensive care unit (ICU) wards patients (
Identifiants
pubmed: 35830989
pii: 43/7/723
doi: 10.15537/smj.2022.43.7.20220213
pmc: PMC9749687
doi:
Substances chimiques
Fibrin Fibrinogen Degradation Products
0
fibrin fragment D
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
723-729Informations de copyright
Copyright: © Saudi Medical Journal.
Références
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Br J Biomed Sci. 2022 Apr 08;79:10098
pubmed: 35996516
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Biomed Res Int. 2022 Feb 16;2022:4620037
pubmed: 35224093
PLoS One. 2022 Jan 14;17(1):e0262600
pubmed: 35030224
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Arch Acad Emerg Med. 2020 Apr 1;8(1):e41
pubmed: 32259130
Lancet Haematol. 2020 Jun;7(6):e438-e440
pubmed: 32407672
Acta Haematol. 2021;144(1):10-23
pubmed: 32721958
Diagnostics (Basel). 2022 Jan 28;12(2):
pubmed: 35204430
Blood. 2020 Jul 23;136(4):489-500
pubmed: 32492712
Front Public Health. 2020 Sep 17;8:506
pubmed: 33042946
Clin Chim Acta. 2020 Jul;506:145-148
pubmed: 32178975
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Travel Med. 2020 May 18;27(3):
pubmed: 32109274
Indian J Crit Care Med. 2017 Dec;21(12):861-864
pubmed: 29307969
Rev Bras Ter Intensiva. 2020 Jun;32(2):197-199
pubmed: 32667446
Blood. 2020 Jul 23;136(4):381-383
pubmed: 32702124
Lancet Haematol. 2020 Jun;7(6):e425
pubmed: 32470428
Chin Med J (Engl). 2020 May 5;133(9):1087-1095
pubmed: 32358325
N Engl J Med. 2020 Apr 23;382(17):e38
pubmed: 32268022
Risk Manag Healthc Policy. 2020 Oct 07;13:1965-1975
pubmed: 33116977
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Diagnostics (Basel). 2022 Jan 12;12(1):
pubmed: 35054342
Ann Transl Med. 2020 Feb;8(3):48
pubmed: 32154288
BMJ. 2020 Apr 21;369:m1443
pubmed: 32317267
Asian J Psychiatr. 2020 Jun;51:102083
pubmed: 32283510